DTx Pharma, Inc. — Form D

DTx Pharma, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-30. The offering totals $1.0M, of which $25K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
Andrew AdamsDirectorLos Angeles, CA
Matthew HammondDirectorVANCOUVER, A1
Jeffrey FriedmanDirectorGrass Lake, MI
Jeffrey FriedmanExecutive OfficerGrass Lake, MI
Daniel BeckerDirectorCambridge, MA
Arthur SuckowDirectorSan Diego, CA
Arthur SuckowExecutive OfficerSan Diego, CA
John RundyDirectorSan Diego, CA
Niki UpperExecutive OfficerSan Diego, CA
Tim ScottDirectorSan Diego, CA
John GrundyDirectorSan Diego, CA
Arthur T SuckowDirectorSAN DIEGO, CA
Arthur T SuckowExecutive OfficerSAN DIEGO, CA
Arthur T SuckowRelated PersonSAN DIEGO, CA
John T GrundyDirectorSAN DIEGO, CA
John T GrundyRelated PersonSAN DIEGO, CA
Jeffrey T FriedmanDirectorSAN DIEGO, CA
Jeffrey T FriedmanRelated PersonSAN DIEGO, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2021-03-10D$100.2M$100.2M
2020-07-06D$5.0M$200K
2019-09-20D/A$12.5M$12.0M
2019-04-23D$7.0M$5.5M
2018-06-15D/A$2.0M$1.0M

More